Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
about
Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamineLisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trialsComparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating DisorderAttention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex.Pharmacological treatment of binge eating disorder: update review and synthesis.Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients.Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients.Tools for Successful Weight Management in Primary CareAre Eating Disorders Related to Attention Deficit/Hyperactivity Disorder?Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.Stimulants for the Control of Hedonic Appetite.Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eatingAttention-deficit/hyperactivity disorder-specific stimulant misuse, mood, anxiety, and stress in college-age women at high risk for or with eating disordersThe Binge and the Brain.Recognizing Binge-Eating Disorder in the Clinical Setting: A Review of the Literature.Long-term, calorie-restricted intake of a high-fat diet in rats reduces impulse control and ventral striatal D2 receptor signalling - two markers of addiction vulnerability.Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.Is impulsive violence an addiction? The Habit Hypothesis.Horizons in the Pharmacotherapy of Obesity.Overview of the treatment of binge eating disorder.A primer on binge eating disorder diagnosis and management.2016 update on eating disorders in athletes: A comprehensive narrative review with a focus on clinical assessment and management.The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis.Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications.Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine.Eating disorders: from bench to bedside and back.Associations between Attention Deficit Hyperactivity Disorder and Eating Disorders by Gender: Results from the National Comorbidity Survey Replication.Effects of lisdexamfetamine in a rat model of binge-eating.A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation.Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorderDopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.Reduced Inhibitory Control Mediates the Relationship Between Cortical Thickness in the Right Superior Frontal Gyrus and Body Mass Index.Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study.Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder.Personality, attrition and weight loss in treatment seeking women with obesity.
P2860
Q26752974-5EC114AE-5C8C-4C30-A2B2-C1D0A9EA7556Q28553322-E1C49220-9F29-4C0B-979B-B5E4513918E7Q30234580-21081F5B-9490-46C6-89FD-C5FDA371B49AQ33590913-92F74201-0B7F-4973-8620-23C80CC918FAQ35486676-4A53F52A-98FC-4B7F-B522-90F1FE135B3EQ35817318-645B5120-33BD-463C-9100-697286FECE06Q36065939-55C58477-C807-4E9A-9125-7445AEDCE502Q36251933-98A061B1-28F6-41AA-AF6A-759EED5F60D2Q36292328-B6FF1209-C556-46DE-92E9-D9D041CAB1D2Q36338832-CFA9F970-28B4-4FD0-ADDA-D718D7E1FFA6Q36649080-A86B196C-0620-4230-8AAA-F563923DE1BBQ36690648-349646F6-1EC2-4F7F-B56D-48B778229EDBQ36830567-063F66BD-8EEE-4723-83CC-876976A0792DQ36977940-5312CD28-0F30-4DE0-BF08-FD934E6F41BDQ36997149-BF6A0D6C-2F9A-4A5E-ACF2-8122B85723FBQ37035652-E5529C81-6488-4188-83FA-4B9E9C4ACB61Q37281318-9580A323-24E5-4BE6-9C41-B3D7492065E3Q38295574-BEA4A1BC-B34D-40D0-99DC-0D1D7C68F1BBQ38370764-73C24018-8CB0-4B0B-A9AC-77357BBCC51CQ38374118-C7BD7A34-1115-4D0E-B520-27ACA1EABAF3Q38442171-B10125D7-83A3-4B3D-87D3-3BA9B57DC48DQ38582461-24CF423A-8F2A-4E60-8204-1B546206C02AQ38643272-29361C57-218C-434C-949E-D8B5708B899CQ38673549-71C2B9C7-6C55-4626-9784-616296893033Q38702227-BF882A13-A882-429D-A571-49DA55C58D1CQ38793954-AC912BC2-B25A-4AAE-AD59-19A719B51ED3Q38810225-7C23233C-AE0C-4EC8-8DC8-EB79EF48DEDFQ38836941-4926D46A-5D29-4772-B25D-21B25FBA6751Q38858169-7A31040B-4B0F-4DCB-8841-60AC8A656E28Q38959757-27F215D3-36AA-4288-AFC1-04ED5700FA9BQ39536338-4026A323-00AB-4A3D-9804-AB3726BA9A9BQ40295381-9924DF70-A116-4C2B-A573-867A00DBA748Q40479721-4EB22B14-DA77-4996-8AA4-90FC9B555FAEQ41539924-A8B471EE-3765-4830-821B-166D943AD649Q41654754-37726F99-CD3D-48DA-8317-97E9461FB675Q42361284-B1C4E33E-8584-4F8C-8EAA-B8BE5F3B8EA2Q42418790-68E09D31-F632-4BA3-92AC-280967A9FDC3Q43126342-03A013BC-89DC-4CF0-861F-E1F0D6D8D1DAQ47289729-CEA77A87-2667-4470-B28C-83A39B4672E6Q47369792-C989C0FD-6495-4C1F-837F-17353C46D7A3
P2860
Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of lisdexa ...... : a randomized clinical trial.
@en
type
label
Efficacy and safety of lisdexa ...... : a randomized clinical trial.
@en
prefLabel
Efficacy and safety of lisdexa ...... : a randomized clinical trial.
@en
P2093
P1433
P1476
Efficacy and safety of lisdexa ...... : a randomized clinical trial.
@en
P2093
Denise Wilfley
James E Mitchell
James I Hudson
Jeffrey Jonas
Jiannong Wang
Joseph Gao
M Celeste Ferreira-Cornwell
Maria Gasior
Susan L McElroy
Timothy Whitaker
P304
P356
10.1001/JAMAPSYCHIATRY.2014.2162
P407
P577
2015-03-01T00:00:00Z